Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.250
+0.040 (3.31%)
At close: Mar 6, 2026, 4:00 PM EST
1.260
+0.010 (0.77%)
After-hours: Mar 6, 2026, 7:59 PM EST
Dermata Therapeutics Market Cap
Dermata Therapeutics has a market cap or net worth of $2.98 million as of March 6, 2026. Its market cap has decreased by -53.99% in one year.
Market Cap
2.98M
Enterprise Value
-1.68M
1-Year Change
-53.99%
Ranking
Category
Stock Price
$1.25
Market Cap Chart
Since the IPO on August 13, 2021, Dermata Therapeutics's market cap has decreased from $57.49M to $2.98M, a decrease of -94.81%. That is a compound annual growth rate of -47.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 2.98M | -51.66% |
| Dec 31, 2025 | 6.17M | 124.01% |
| Dec 31, 2024 | 2.76M | 27.62% |
| Dec 29, 2023 | 2.16M | -56.38% |
| Dec 30, 2022 | 4.95M | -65.85% |
| Dec 31, 2021 | 14.49M | -74.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HCW Biologics | 3.63M |
| GRI Bio | 3.47M |
| SciSparc | 3.14M |
| XORTX Therapeutics | 3.05M |
| Scinai Immunotherapeutics | 2.82M |
| Enveric Biosciences | 2.75M |
| Jaguar Health | 2.73M |
| Propanc Biopharma | 2.67M |